Keyphrases
Randomized Placebo-controlled Trial
100%
Chronic Pelvic Pain Syndrome
100%
Pentosan Polysulfate Sodium
100%
Chronic Prostatitis Symptom Index
50%
Placebo
37%
Global Improvement
37%
Placebo Groups
25%
Tolerability
12%
Adverse Events
12%
Headache
12%
Symptom Severity
12%
Statistical Significance
12%
Nausea
12%
National Institutes of Health
12%
Clinical Diagnosis
12%
Index Assessment
12%
Quality of Life Domains
12%
Diarrhea
12%
Pentosan Polysulfate
12%
Domain Scores
12%
Category III
12%
Subjective Global Assessment
12%
Primary Outcome Measure
12%
Severity Index
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pentosan Polysulfate
100%
Pelvis Pain Syndrome
100%
Placebo-Controlled Study
100%
Symptom
66%
Placebo
55%
Chronic Prostatitis
44%
Adverse Event
11%
Tolerability
11%
Nausea
11%
Headache
11%
Diarrhea
11%
Neuroscience
Placebo
100%
Pelvis
100%
Pentosan Polysulfate
100%
Headache
11%